HNI CORP (HNI) Fundamental Analysis & Valuation

NYSE:HNI • US4042511000

Current stock price

35.32 USD
-1.83 (-4.93%)
At close:
35.32 USD
0 (0%)
After Hours:

This HNI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. HNI Profitability Analysis

1.1 Basic Checks

  • In the past year HNI was profitable.
  • HNI had a positive operating cash flow in the past year.
  • Of the past 5 years HNI 4 years were profitable.
  • HNI had a positive operating cash flow in 4 of the past 5 years.
HNI Yearly Net Income VS EBIT VS OCF VS FCFHNI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

  • HNI's Return On Assets of 7.68% is amongst the best of the industry. HNI outperforms 80.49% of its industry peers.
  • The Return On Equity of HNI (16.94%) is better than 80.49% of its industry peers.
  • The Return On Invested Capital of HNI (12.16%) is better than 78.05% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for HNI is in line with the industry average of 10.58%.
  • The 3 year average ROIC (10.10%) for HNI is below the current ROIC(12.16%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.68%
ROE 16.94%
ROIC 12.16%
ROA(3y)6.25%
ROA(5y)5.14%
ROE(3y)14.39%
ROE(5y)12.08%
ROIC(3y)10.1%
ROIC(5y)9.3%
HNI Yearly ROA, ROE, ROICHNI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • HNI's Profit Margin of 5.46% is fine compared to the rest of the industry. HNI outperforms 69.51% of its industry peers.
  • HNI's Profit Margin has improved in the last couple of years.
  • HNI has a Operating Margin of 8.75%. This is in the better half of the industry: HNI outperforms 64.63% of its industry peers.
  • In the last couple of years the Operating Margin of HNI has grown nicely.
  • The Gross Margin of HNI (41.49%) is better than 73.17% of its industry peers.
  • In the last couple of years the Gross Margin of HNI has grown nicely.
Industry RankSector Rank
OM 8.75%
PM (TTM) 5.46%
GM 41.49%
OM growth 3Y23.18%
OM growth 5Y4.73%
PM growth 3Y26.35%
PM growth 5Y2.34%
GM growth 3Y5.48%
GM growth 5Y2.07%
HNI Yearly Profit, Operating, Gross MarginsHNI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

7

2. HNI Health Analysis

2.1 Basic Checks

  • HNI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • HNI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
HNI Yearly Shares OutstandingHNI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
HNI Yearly Total Debt VS Total AssetsHNI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 3.36 indicates that HNI is not in any danger for bankruptcy at the moment.
  • HNI has a better Altman-Z score (3.36) than 73.17% of its industry peers.
  • HNI has a debt to FCF ratio of 1.80. This is a very positive value and a sign of high solvency as it would only need 1.80 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.80, HNI belongs to the top of the industry, outperforming 82.93% of the companies in the same industry.
  • HNI has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
  • HNI has a Debt to Equity ratio of 0.40. This is comparable to the rest of the industry: HNI outperforms 59.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 1.8
Altman-Z 3.36
ROIC/WACC1.48
WACC8.24%
HNI Yearly LT Debt VS Equity VS FCFHNI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

  • HNI has a Current Ratio of 1.33. This is a normal value and indicates that HNI is financially healthy and should not expect problems in meeting its short term obligations.
  • HNI has a Current ratio (1.33) which is comparable to the rest of the industry.
  • A Quick Ratio of 0.85 indicates that HNI may have some problems paying its short term obligations.
  • HNI has a worse Quick ratio (0.85) than 71.95% of its industry peers.
  • The current and quick ratio evaluation for HNI is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 0.85
HNI Yearly Current Assets VS Current LiabilitesHNI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. HNI Growth Analysis

3.1 Past

  • HNI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.73%, which is quite good.
  • Measured over the past years, HNI shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.35% on average per year.
EPS 1Y (TTM)13.73%
EPS 3Y16.69%
EPS 5Y14.35%
EPS Q2Q%-4.6%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%38.27%

3.2 Future

  • The Earnings Per Share is expected to grow by 16.83% on average over the next years. This is quite good.
  • HNI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.24% yearly.
EPS Next Y19.57%
EPS Next 2Y18.56%
EPS Next 3YN/A
EPS Next 5Y16.83%
Revenue Next Year129.43%
Revenue Next 2Y54.13%
Revenue Next 3YN/A
Revenue Next 5Y23.24%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
HNI Yearly Revenue VS EstimatesHNI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2029 2030 2B 4B 6B
HNI Yearly EPS VS EstimatesHNI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2029 2030 2 4 6

9

4. HNI Valuation Analysis

4.1 Price/Earnings Ratio

  • HNI is valuated reasonably with a Price/Earnings ratio of 10.15.
  • HNI's Price/Earnings ratio is rather cheap when compared to the industry. HNI is cheaper than 89.02% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of HNI to the average of the S&P500 Index (25.79), we can say HNI is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 8.49, the valuation of HNI can be described as reasonable.
  • 89.02% of the companies in the same industry are more expensive than HNI, based on the Price/Forward Earnings ratio.
  • HNI is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.80, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.15
Fwd PE 8.49
HNI Price Earnings VS Forward Price EarningsHNI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • HNI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. HNI is cheaper than 92.68% of the companies in the same industry.
  • 87.80% of the companies in the same industry are more expensive than HNI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.54
EV/EBITDA 5.83
HNI Per share dataHNI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • HNI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The excellent profitability rating of HNI may justify a higher PE ratio.
  • HNI's earnings are expected to grow with 18.56% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.52
PEG (5Y)0.71
EPS Next 2Y18.56%
EPS Next 3YN/A

8

5. HNI Dividend Analysis

5.1 Amount

  • HNI has a Yearly Dividend Yield of 3.36%.
  • Compared to an average industry Dividend Yield of 0.80, HNI pays a better dividend. On top of this HNI pays more dividend than 90.24% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.91, HNI pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.36%

5.2 History

  • The dividend of HNI has a limited annual growth rate of 3.58%.
  • HNI has paid a dividend for at least 10 years, which is a reliable track record.
  • HNI has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)3.58%
Div Incr Years14
Div Non Decr Years26
HNI Yearly Dividends per shareHNI Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • 44.63% of the earnings are spent on dividend by HNI. This is a bit on the high side, but may be sustainable.
  • The dividend of HNI is growing, but earnings are growing more, so the dividend growth is sustainable.
DP44.63%
EPS Next 2Y18.56%
EPS Next 3YN/A
HNI Yearly Income VS Free CF VS DividendHNI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
HNI Dividend Payout.HNI Dividend Payout, showing the Payout Ratio.HNI Dividend Payout.PayoutRetained Earnings

HNI Fundamentals: All Metrics, Ratios and Statistics

HNI CORP

NYSE:HNI (3/18/2026, 8:13:33 PM)

After market: 35.32 0 (0%)

35.32

-1.83 (-4.93%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)02-25
Earnings (Next)05-05
Inst Owners128.59%
Inst Owner Change27.32%
Ins Owners1.81%
Ins Owner Change1.5%
Market Cap1.62B
Revenue(TTM)N/A
Net Income(TTM)141.60M
Analysts80
Price Target72.17 (104.33%)
Short Float %3.94%
Short Ratio2.7
Dividend
Industry RankSector Rank
Dividend Yield 3.36%
Yearly Dividend1.35
Dividend Growth(5Y)3.58%
DP44.63%
Div Incr Years14
Div Non Decr Years26
Ex-Date03-02
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.18%
Min EPS beat(2)1.98%
Max EPS beat(2)28.39%
EPS beat(4)4
Avg EPS beat(4)18.82%
Min EPS beat(4)1.98%
Max EPS beat(4)28.39%
EPS beat(8)8
Avg EPS beat(8)28.21%
EPS beat(12)12
Avg EPS beat(12)82.31%
EPS beat(16)16
Avg EPS beat(16)68.46%
Revenue beat(2)1
Avg Revenue beat(2)0.2%
Min Revenue beat(2)-1.78%
Max Revenue beat(2)2.18%
Revenue beat(4)2
Avg Revenue beat(4)-0.12%
Min Revenue beat(4)-3.18%
Max Revenue beat(4)2.31%
Revenue beat(8)3
Avg Revenue beat(8)-1.33%
Revenue beat(12)5
Avg Revenue beat(12)-0.8%
Revenue beat(16)8
Avg Revenue beat(16)-0.9%
PT rev (1m)0%
PT rev (3m)5.6%
EPS NQ rev (1m)0.55%
EPS NQ rev (3m)-0.44%
EPS NY rev (1m)0.14%
EPS NY rev (3m)0.14%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.92%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.79%
Valuation
Industry RankSector Rank
PE 10.15
Fwd PE 8.49
P/S 0.62
P/FCF 8.54
P/OCF 6.47
P/B 1.94
P/tB 6.98
EV/EBITDA 5.83
EPS(TTM)3.48
EY9.85%
EPS(NY)4.16
Fwd EY11.78%
FCF(TTM)4.13
FCFY11.7%
OCF(TTM)5.46
OCFY15.45%
SpS56.57
BVpS18.24
TBVpS5.06
PEG (NY)0.52
PEG (5Y)0.71
Graham Number37.79
Profitability
Industry RankSector Rank
ROA 7.68%
ROE 16.94%
ROCE 15.82%
ROIC 12.16%
ROICexc 12.4%
ROICexgc 21.74%
OM 8.75%
PM (TTM) 5.46%
GM 41.49%
FCFM 7.31%
ROA(3y)6.25%
ROA(5y)5.14%
ROE(3y)14.39%
ROE(5y)12.08%
ROIC(3y)10.1%
ROIC(5y)9.3%
ROICexc(3y)10.32%
ROICexc(5y)9.75%
ROICexgc(3y)18.8%
ROICexgc(5y)18.69%
ROCE(3y)13.14%
ROCE(5y)12.1%
ROICexgc growth 3Y10.64%
ROICexgc growth 5Y-2.01%
ROICexc growth 3Y13.99%
ROICexc growth 5Y-0.96%
OM growth 3Y23.18%
OM growth 5Y4.73%
PM growth 3Y26.35%
PM growth 5Y2.34%
GM growth 3Y5.48%
GM growth 5Y2.07%
F-Score8
Asset Turnover1.41
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 1.8
Debt/EBITDA 1.01
Cap/Depr 58.78%
Cap/Sales 2.34%
Interest Coverage 250
Cash Conversion 75.81%
Profit Quality 133.83%
Current Ratio 1.33
Quick Ratio 0.85
Altman-Z 3.36
F-Score8
WACC8.24%
ROIC/WACC1.48
Cap/Depr(3y)71.22%
Cap/Depr(5y)69.5%
Cap/Sales(3y)2.75%
Cap/Sales(5y)2.68%
Profit Quality(3y)172.64%
Profit Quality(5y)207.79%
High Growth Momentum
Growth
EPS 1Y (TTM)13.73%
EPS 3Y16.69%
EPS 5Y14.35%
EPS Q2Q%-4.6%
EPS Next Y19.57%
EPS Next 2Y18.56%
EPS Next 3YN/A
EPS Next 5Y16.83%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%38.27%
Revenue Next Year129.43%
Revenue Next 2Y54.13%
Revenue Next 3YN/A
Revenue Next 5Y23.24%
EBIT growth 1Y1.25%
EBIT growth 3Y29.3%
EBIT growth 5Y7.21%
EBIT Next Year66.69%
EBIT Next 3Y52.79%
EBIT Next 5Y36.38%
FCF growth 1Y48.86%
FCF growth 3Y38.73%
FCF growth 5Y2.65%
OCF growth 1Y19.21%
OCF growth 3Y19.88%
OCF growth 5Y0.66%

HNI CORP / HNI Fundamental Analysis FAQ

What is the fundamental rating for HNI stock?

ChartMill assigns a fundamental rating of 7 / 10 to HNI.


Can you provide the valuation status for HNI CORP?

ChartMill assigns a valuation rating of 9 / 10 to HNI CORP (HNI). This can be considered as Undervalued.


What is the profitability of HNI stock?

HNI CORP (HNI) has a profitability rating of 8 / 10.


What is the valuation of HNI CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for HNI CORP (HNI) is 10.15 and the Price/Book (PB) ratio is 1.94.


How financially healthy is HNI CORP?

The financial health rating of HNI CORP (HNI) is 7 / 10.